IRIS
MAFFIOLI, PAMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.219
AS - Asia 7.635
EU - Europa 5.429
SA - Sud America 1.164
AF - Africa 269
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.985
CN - Cina 3.910
SG - Singapore 1.641
IE - Irlanda 1.180
UA - Ucraina 934
BR - Brasile 884
DE - Germania 766
HK - Hong Kong 755
FI - Finlandia 676
VN - Vietnam 588
RU - Federazione Russa 520
IT - Italia 337
FR - Francia 331
SE - Svezia 270
GB - Regno Unito 224
ZA - Sudafrica 157
CA - Canada 141
IN - India 138
BD - Bangladesh 130
AR - Argentina 97
IQ - Iraq 56
MX - Messico 55
EC - Ecuador 54
TR - Turchia 52
JP - Giappone 51
ID - Indonesia 42
NL - Olanda 38
CO - Colombia 36
PK - Pakistan 34
UZ - Uzbekistan 28
ES - Italia 25
PH - Filippine 25
VE - Venezuela 24
PL - Polonia 22
MA - Marocco 21
JO - Giordania 20
MY - Malesia 20
PE - Perù 19
SA - Arabia Saudita 18
TN - Tunisia 18
IR - Iran 17
CL - Cile 16
EG - Egitto 16
PY - Paraguay 16
AL - Albania 13
IL - Israele 13
TH - Thailandia 12
BE - Belgio 11
KE - Kenya 11
AT - Austria 10
KZ - Kazakistan 10
AU - Australia 9
BH - Bahrain 9
BO - Bolivia 9
MU - Mauritius 9
RO - Romania 9
AZ - Azerbaigian 8
DZ - Algeria 8
ET - Etiopia 8
NZ - Nuova Zelanda 8
PA - Panama 8
JM - Giamaica 7
KR - Corea 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
HU - Ungheria 6
LT - Lituania 6
NP - Nepal 6
AM - Armenia 5
CH - Svizzera 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
MD - Moldavia 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
EE - Estonia 4
GR - Grecia 4
LV - Lettonia 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GE - Georgia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GT - Guatemala 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
NC - Nuova Caledonia 2
PS - Palestinian Territory 2
SN - Senegal 2
Totale 23.707
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.326
Dublin 1.180
Chandler 1.053
Nanjing 1.001
San Jose 979
Singapore 787
Hong Kong 739
Dallas 712
Ashburn 683
Boardman 430
Nanchang 421
Beijing 354
Shenyang 300
Hebei 283
Princeton 283
Lawrence 275
Medford 267
Lauterbourg 266
Changsha 257
Wilmington 253
Jiaxing 221
Los Angeles 214
Ho Chi Minh City 213
Munich 174
Hangzhou 171
Helsinki 156
Tianjin 149
Hanoi 139
Johannesburg 136
Redondo Beach 123
Buffalo 121
Council Bluffs 102
Moscow 93
São Paulo 87
New York 78
Toronto 75
Shanghai 58
Cambridge 56
Ann Arbor 53
Milan 53
Seattle 51
Santa Clara 49
Woodbridge 49
Tokyo 47
Orem 36
Fairfield 33
Norwalk 33
Turku 31
Da Nang 29
Jinan 29
Montreal 29
San Francisco 28
Des Moines 27
Rio de Janeiro 27
Tashkent 26
Baghdad 25
Chennai 25
Frankfurt am Main 25
Quito 25
Brooklyn 24
Guangzhou 23
Haiphong 23
Kunming 23
Phoenix 21
Zhengzhou 21
Bruino 19
Chicago 19
Dhaka 19
Pavia 19
Stockholm 19
Belo Horizonte 18
Campinas 18
London 18
Amman 17
Genova 17
Pune 17
Boston 16
The Dalles 16
Curitiba 15
Guayaquil 15
Ankara 14
Lima 14
Warsaw 14
Atlanta 13
Bologna 13
Falkenstein 13
Ningbo 13
Orange 13
Piscataway 13
Salvador 13
Bogotá 12
Charlotte 12
Hải Dương 12
Lahore 12
Biên Hòa 11
Denver 11
Mexico City 11
Riyadh 11
Rome 11
Brasília 10
Totale 15.588
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 244
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 202
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 186
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 155
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 152
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 143
Abscisic Acid Treatment in Patients with Prediabetes. 142
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 134
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 131
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 131
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 130
Adipocytokines levels in obese and non-obese subjects, an observational study 129
Effetti sulla variabilità glicemica e sul compenso glico-metabolico di metformina, pioglitazone e sitagliptin in pazienti affetti da diabete mellito di tipo 2 129
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 128
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 127
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 127
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 127
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 126
Diarrea in paziente diabetico 124
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 123
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 123
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 122
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 122
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 121
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 121
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 117
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 116
A curious case of hypoglycaemia 113
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 113
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 112
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 111
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 110
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 110
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 108
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 108
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 106
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 106
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 106
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 105
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 104
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 104
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 103
Effects of berberine on lipid profile in subjects with low cardiovascular risk 100
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 100
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 100
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 100
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients 100
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 98
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus 96
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 96
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation 96
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 96
Aerobic physical activity in obese subjects compared to anaerobic/aerobic physical activity 94
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 94
Effects of thiazolidinediones and sulfonylureas in patients with diabetes 93
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 93
Current and emerging pharmacotherapies for the management of hypertension, focus on aliskiren 93
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 93
A role for quercetin in coronavirus disease 2019 (COVID-19) 92
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 92
Candesartan effect on inflammation in hypertension 92
Valutazione dei livelli di metalloproteasi 2 e 9 e dei loro inibitori nei soggetti con dislipidemia combinata 92
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 92
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 91
Effetti di un carico lipidico orale sui marcatori di rimodellamento vascolare nei soggetti sani 91
Effetto del telmisartan sui marcatori infiammatori a digiuno e postprandiale nei pazienti diabetici ipertesi 91
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation. 91
Hypoglycemia, its implications in the clinical practice, and possible ways to prevent it. 91
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 90
Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. 90
Sitagliptin in aggiunta alla precedente terapia ipoglicemizzante sull'insulino-resistenza e il profilo lipidico: uno studio a due anni 90
Effetti di un anno di trattamento con exenatide paragonato a glibenclamide in pazienti diabetici di tipo 2 90
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 90
Matrix metalloproteinase-2 and – 9 levels in obese patients 89
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 89
Evaluation of candesartan compared to olmesartan on insulin sensitivity-related parameters in type 2 diabetic hypertensive patients 89
Valutazione dell’infiammazione e delle MMPs nei soggetti con e senza diabete durante OGTT 89
Anti-obesity drugs: a review about their effects and their safety 88
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia during omega-3 polyunsaturated fatty acids therapy 88
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study 88
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 87
Treatment options for hypercholesterolemia and combined dyslipidemia: focus on pitavastatin 87
Effetti di un carico lipidico orale sui marcatori di infiammazione e stress endoteliale nei soggetti sani 87
Rosiglitazone maleate and glimepiride in fixed combination for the metabolic control of type 2 diabetes 87
Metformina in bustine rispetto a metformina nella classica formulazione in compresse: primi risultati di uno studio clinico 87
Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus. 87
Impact of the glyco-metabolic control on erectile dysfunction in patients with type 2 diabetes mellitus 86
Effects of berberine on lipid profile in subjects with low cardiovascular risk 86
Effetti di sitagliptin o metformina associati a pioglitazone in pazienti diabetici scarsamente controllati 86
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 86
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial 86
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 85
Pharmacotherapy for Obesity 85
Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals 85
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici di tipo 2 85
Effetti della formulazione idrosolubile di metformina sul compenso glicemico e sulla qualità della vita in pazienti con diabete mellito di tipo 2 84
Effetti di sitagliptin rispetto a glibenclamide in aggiunta a metformina e pioglitazone in pazienti diabetici di tipo 2 84
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 84
Comparison of vildagliptin and glimepiride: effects on glycemic control, fat tolerance, and inflammatory markers in people with type 2 diabetes 84
Totale 10.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/20221.031 9 4 65 9 4 6 8 58 59 7 175 627
2022/20233.250 358 193 6 221 372 348 2 198 1.370 40 94 48
2023/20241.058 120 196 37 73 121 257 16 120 9 33 37 39
2024/20253.371 24 329 98 110 70 89 246 284 718 77 368 958
2025/20267.930 552 588 1.066 1.006 817 310 1.495 343 647 556 405 145
Totale 24.087